Login to your account

Username *
Password *
Remember Me
FDA In Brief: FDA advises against use of SARS-CoV-2 antibody test results to evaluate immunity or protection from COVID-19, including after vaccination.

FDA In Brief: FDA advises against use of SARS-CoV-2 antibody test results to evaluate immunity or protection from COVID-19, including after vaccination.

Bibliographie
20 mai 2021
Soyez le premier à commenter!

FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination – U.S. Food & Drug Administration   Commentary on Twitter (thread – click for more) Today, we issued a safety communication notifying the public and providers that results from SARS-CoV-2 antibody tests should […]

The post FDA In Brief: FDA advises against use of SARS-CoV-2 antibody test results to evaluate immunity or protection from COVID-19, including after vaccination. appeared first on Links Medicus.

Lu 557 fois
Évaluer cet élément
(0 Votes)
Plus dans cette catégorie : « One year after hospital discharge due to SARS-CoV-2 Infection, the prevalence of long-term cough, chest pain, dyspnea, and fatigue was 2.5%, 6.5%, 23.3%, and 61.2%, respectively Systematic review and meta-analysis of observational studies suggest low-dose aspirin may be of benefit for patients with Covid-19 – the finds require further investigation in randomized studies. »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.

Retour en haut

Search